Skip to main content
. 2018 Mar 6;9(3):355–363. doi: 10.1007/s41999-018-0038-2

Table 1.

Patient demographics, severity of illness, clinical management and outcome in 617 methicillin-sensitive Staphylococcus aureus bacteremia patients stratified according to break-point age of 60 years and presence of formal (bedside) infectious specialist consultation (ISC)

Patient characteristics Group 1
≥ 60 years
Formal ISC present
n = 250
Group 2
≥ 60 years
Formal ISC absent
n = 36
Group 3
< 60 years
Formal ISC present
n = 270
Group 1 vs. group 2 Group 1 vs. group 3
OR (95% CI) p value OR (95% CI) p value
Demographics
 Male sex 144 (58) 23 (64) 182 (67) 0.77 (0.37–1.59) 0.47 0.65 (0.46–0.94) 0.21
 Age, yearsa 72.6 ± 7.6 71.1 ± 7.9 43.0 ± 12.3 0.29 < 0.001
 Healthcare-acquired 157 (63) 19 (53) 118 (44) 1.51 (0.75–3.05) 0.25 2.18 (1.53–3.09) < 0.001
 Previous hospitalizationb 154 (62) 25 (69) 114 (42) 0.71 (0.33–1.50) 0.36 2.19 (1.55–3.12) < 0.001
 Healthy-nonfatalc 153 (61) 19 (53) 230 (85) 1.41 (0.69–2.85) 0.34 0.27 (0.18–0.42) < 0.001
 Severe sepsisd 21 (8) 5 (14) 18 (7) 0.57 (0.20–1.62) 0.28 1.28 (0.67–2.47) 0.45
Infection foci
 Deep infections 200 (80) 19 (53) 222 (82) 3.58 (1.74–7.38) < 0.001 0.87 (0.56–1.34) 0.52
 Pneumonia 99 (40) 12 (33) 103 (38) 1.31 (0.63–2.74) 0.47 1.06 (0.75–1.51) 0.73
 Endocarditis 39 (16) 2 (6) 47 (17) 3.14 (0.73–13.6) 0.11 0.88 (0.55–1.39) 0.58
 Osteomyelitise 94 (38) 3 (8) 110 (41) 6.63 (1.98–22.2) 0.001 0.87 (0.61–1.24) 0.44
 Deep abscesses 85 (34) 2 (6) 143 (53) 8.76 (2.05–37.3) 0.001 0.46 (0.32–0.65) 0.001
 Any foreign body infection 59 (24) 4 (11) 27 (10) 2.47 (0.84–7.27) 0.09 2.78 (1.69–4.55) 0.001
 Infected PVC or CVCf 45 (18) 0 32 (12) 1.48 (0.89–2.44) 0.12
Clinical management
 TTE echocardiographyg 165 (66) 19 (53) 174 (64) 1.74 (0.86–3.51) 0.12 1.07 (0.75–1.54) 0.71
 TEE echocardiographyg 55 (22) 2 (6) 54 (21) 4.79 (1.12–20.6) 0.021 1.13 (0.74–1.72) 0.58
 Any infection foci removal 84 (34) 0 94 (36) 0.95 (0.66–1.36) 0.77
 Heart valve replacement 2 (< 1) 0 4 (1) 0.54 (0.09–2.95) 0.47
 Infected joint lavage 7 (3) 0 6 (2) 1.27 (0.42–3.82) 0.67
Standard antibiotics
 Cloxacillin 163 (65) 0 165 (61) 1.19 (0.83–1.70) 0.33
 Cephalosporin 70 (28) 27 (75) 85 (31) 0.13 (0.06–0.29) < 0.001 0.85 (0.58–1.23) 0.39
 Other antibiotics 17 (7) 9 (25) 20 (7) 4.57 (1.87–11.2) < 0.001 1.09 (0.56–2.14) 0.79
 Treatment durationh 24.6 ± 13 19.8 ± 15 26.1 ± 12 0.038 0.19
Adjunctive antibiotics
 Fluoroquinolone 129 (52) 11 (31) 136 (50) 2.42 (1.14–5.14) 0.018 1.05 (0.75–1.48) 0.78
 Rifampicin 152 (61) 11 (31) 175 (65) 3.53 (1.66–7.49) 0.001 0.84 (0.59–1.20) 0.34
Outcome
 Hospital durationh 38.7 ± 34 31.6 ± 26 32.7 ± 29 0.09 0.10
 Mortality in 28 days 46 (18) 11 (31) 12 (4) 0.51 (0.24–1.12) 0.088 4.85 (2.50–9.39) < 0.001
 Mortality in 90 days 61 (24) 17 (47) 21 (8) 0.36 (0.18–0.74) 0.004 3.83 (2.25–6.51) < 0.001

Altogether 61 (18%) patients were aged < 60 years and received no formal ISC and are omitted in the presentation. Values are expressed as number of patients (%), odds ratios (ORs) with 95% confidence intervals (CI) and mean ± standard deviation (SD)

aStudent’s t test (mean ± SD)

bWithin 2 months preceding SAB

cMcCabe’s classification [20]

dAt blood culture collection

eIncluding septic arthritis

fPeripheral or central venous catheter

gThoracic or –esophageal

hDays (mean ± SD)